Vascular Endothelial Dysfunction in Sleep Apnea — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
United States
Columbia University Irving Medical Center, New York, New York Last updated February 2026